Vancouver-based Geyser Brands’ (TSX.V: GYSR) licensed producer (“LP”),
Apothecary Botanicals, recently secured license amendment approval from Health
Canada to update its 7,000-square-foot facility located in Port Coquitlam,
British Columbia. An article discussing Geyser reads, “This expansion,
anticipated to be complete by the end of June 2019, would allow for research
and development (R&D) and processing capabilities in anticipation of
receiving its licensed amendments. GYSR’s R&D license is pending Health
Canada’s approval of the LP facility, though the company’s facility was
recently audited by Health Canada and found to be fully compliant. The company
hopes to enhance its long-term success through attaining a processing license,
which Geyser Brands believes will help it capitalize in the CBD wellness
product market that’s predicted to be a multibillion-dollar industry (http://ibn.fm/J7DNm). . . . The
company’s facility expansion is anticipated to include mothering and cloning
rooms, along with designated areas for working with approved seed banks. A
focus on processing quality will allow Geyser Brands to ensure high-CBD seed
strains with consistent cannabinoid profiles, providing a reliable quality
experience for consumers via its products.”
To view the full article, visit http://ibn.fm/z55h1
About Geyser Brands Inc.
Geyser Brands builds health-based, hemp-CBD consumer
products in the nutraceutical, cosmetics, food-and-beverage and pet sectors
worldwide. R&D investment in NanoFusion, a proprietary all-natural
nanotechnology, delivers topical, cream, beverages and baked goods, oil, and
tincture formulations with superior bioavailability and water solubility.
Geyser Brands is a Health Canada-approved licensed producer (“LP”) in Port
Coquitlam, British Columbia, that holds a cultivation license and is
anticipating its processing and sales licenses. The company is exclusively
focusing on leveraging these assets to provide the regulatory infrastructure
for its global brands and distribution strategy, as well as acquiring hemp- and
plant-based brands and infusing them with new CBD product lines in
jurisdictions where the therapeutic ingredient is legal. The company’s
proprietary NanoFusion technology surrounds oils and solves for the
insolubility of CBD. Geyser Brands will utilize its 7,000-square-foot licensed
facility in British Columbia for the manufacturing and international
distribution of its hemp- and CBD-based products. For more information, visit
the company’s website at www.GeyserBrands.com.
NOTE TO INVESTORS: The latest news and updates
relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment